ALL Multiplex Panel - 6 Fusions [T(9;22),T(12;21),T(1;19),T(4;11) T(9;11) T(11;19)
- Report in 1 hr
- Serum
₹10,000
Price
₹15,000
or call 77900 98009
AML MULTIPLEX ADVANCE (BCR-ABL, PML-RARA, AML-ETO, Inv 16, NPM1, FLT3, CEBPA)
₹15,000
The AML multiplex advance panel detects seven key genetic changes in acute myeloid leukemia (AML) using molecular testing:
Results guide ELN risk classification, treatment, transplant decisions, and MRD monitoring.
An AML multiplex advance panel is advised by a hematologist at the time of AML diagnosis, ideally before starting treatment, to assess risk and identify targeted therapy options. It is urgent when APL is suspected, especially with bleeding or clotting problems. It may be repeated during and after treatment to monitor residual disease and detect relapse.
No fasting is required for an AML multiplex advance panel done on a blood sample. If a bone marrow sample is needed, inform your doctor about blood thinners or bleeding disorders, and fast only if sedation is planned. Ideally, give the sample before starting chemotherapy. Samples must reach the lab promptly, as RNA degrades quickly.
No, fasting is not required for an AML multiplex advance panel when a blood sample is used. You can eat and drink normally. However, if the test is done on a bone marrow sample under sedation, you may need to fast for 4–6 hours. Follow your doctor’s specific instructions.
₹10,000
₹23,000
₹7,000
₹9,540
Tell us what your doctor has prescribed and our team will confirm the right test and book it for you.